Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cortexyme, Inc. (CRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.68+0.12 (+1.14%)
At close: 04:00PM EST
10.51 -0.17 (-1.59%)
After hours: 07:57PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close12.05
Open11.72
Bid0.00 x 1000
Ask10.60 x 800
Day's Range11.35 - 11.94
52 Week Range10.15 - 121.98
Volume483,878
Avg. Volume2,359,425
Market Cap319.093M
Beta (5Y Monthly)0.26
PE Ratio (TTM)N/A
EPS (TTM)-2.94
Earnings DateOct 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est64.57
  • Motley Fool

    Why Cortexyme Stock Imploded in 2021

    The clinical-stage drugmaker's shares imploded last year in response to the failure of its lead Alzheimer's disease candidate atuzaginstat in a combined phase 2/3 study. Specifically, atuzaginstat reportedly missed both of its co-primary endpoints in the phase 2/3 Gain trial as a treatment for mild to moderate forms of Alzheimer's disease. Since announcing these disappointing trial results late last year, Cortexyme has said that it plans to trial the drug yet again.

  • InvestorPlace

    3 Most-Shorted Stocks at 52-Week Lows to Buy

    Has Wall Street gotten ahead of itself? Depending on where one looks, it’s a fair enough question these days. But that certainly doesn’t include the market’s most-shorted stocks. Let’s take a look both off and on the price charts of three of last year’s heavily-shorted stocks at 52-week lows, which today are better-equipped to usher in a much happier 2022 for bullish investors. The start to the new year has been filled with highs and lows for index investors. After striking record breaking price

  • Simply Wall St.

    Do Institutions Own Cortexyme, Inc. (NASDAQ:CRTX) Shares?

    If you want to know who really controls Cortexyme, Inc. ( NASDAQ:CRTX ), then you'll have to look at the makeup of its...

Advertisement
Advertisement